Research Topics
| J L BrandesSummaryAffiliation: Nashville Neuroscience Group Country: USA Publications
| Collaborators
|
Detail Information
Publications
Treatment approaches to maximizing therapeutic response in migraineJan Lewis Brandes
Department of Neurology, Vanderbilt University School of Medicine, Nashville, TN, USA
Neurology 61:S21-6. 2003..Assessing the presence of any coexisting conditions, such as depression or anxiety, is another essential part of managing migraine...
Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosingJ L Brandes
Nashville Neuroscience Group, Nashville, TN 37203, USA
Cephalalgia 25:735-42. 2005..Eletriptan was well-tolerated, with adverse event rates similar to placebo when mild headaches were treated...
Strategies for optimizing management of menstrual migraineVincent Martin
University of Cincinnati, College of Medicine, Ohio, USA
J Fam Pract 54:S1-7; quiz S8. 2005
Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraineJan Lewis Brandes
Department of Neurology, Vanderbilt University School of Medicine, Nashville, TN, USA
Headache 47:886-94. 2007..The tolerability of naratriptan administered intermittently for prophylaxis for MRM over the long term has not been assessed...
Migraine and functional impairmentJan Lewis Brandes
Saint Thomas Health Services, Nashville Neuroscience Group, Departmentof Neurology, Vanderbilt University School of Medicine, 300 Twentieth Ave N, Suite 603, Nashville, TN 37203, USA
CNS Drugs 23:1039-45. 2009....
Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacksJ L Brandes
Nashville Neuroscience Group, PC, Vanderbilt University School of Medicine, Nashville, TN, USA 37203
Cephalalgia 29:1133-48. 2009..d. (P < 0.001) and b.i.d. (P < 0.001) vs. placebo. Both frovatriptan regimens were well tolerated. In women with difficult-to-treat MM, a 6-day regimen of frovatriptan significantly reduced MM incidence and severity...
Headache related to pregnancy: management of migraine and migraine headache in pregnancyJan Lewis Brandes
Jan Lewis Brandes, MD Nashville Neuroscience Group Department of Neurology, Vanderbilt University School of Medicine, 300 20th Avenue North, Suite 603, Nashville, TN 37203, USA
Curr Treat Options Neurol 10:12-9. 2008..Collaboration between headache specialists and obstetricians is needed to promote research and education for the optimal management of headache during pregnancy...
Sumatriptan-naproxen for acute treatment of migraine: a randomized trialJan Lewis Brandes
Nashville Neuroscience Group, Nashville, Tenn 37203, USA
JAMA 297:1443-54. 2007..Multiple pathogenic mechanisms may be involved in generating the migraine symptom complex, and multimechanism-targeted therapy may confer advantages over monotherapy...
Assessing the ability of topiramate to improve the daily activities of patients with migraineJan Lewis Brandes
Nashville Neuroscience Group, 300 20th Ave N, Suite 603, Nashville, TN 37203, USA
Mayo Clin Proc 81:1311-9. 2006..To assess the impact of topiramate on the daily activities of patients with migraine...
The influence of estrogen on migraine: a systematic reviewJan Lewis Brandes
Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tenn, USA
JAMA 295:1824-30. 2006..Menstrual migraine affects approximately 50% to 60% of female migraineurs, but knowledge regarding the role of hormones, especially estrogen, appears incomplete...
Topiramate for migraine prevention: a randomized controlled trialJan Lewis Brandes
Nashville Neuroscience Group, Nashville, Tenn 37203, USA
JAMA 291:965-73. 2004..Small open-label and controlled trials suggest that the antiepileptic drug topiramate is effective for migraine prevention...
History of childhood maltreatment is associated with comorbid depression in women with migraineG E Tietjen
Department of Neurology, College of Medicine, The University of Toledo Health Science Campus, Toledo, OH 43614, USA
Neurology 69:959-68. 2007..Our objective is to determine, within a headache clinic population of women, if depression moderates the abuse-migraine relationship...
High prevalence of somatic symptoms and depression in women with disabling chronic headacheG E Tietjen
Department of Neurology, The University of Toledo Health Science Campus, Toledo, OH 43614, USA
Neurology 68:134-40. 2007..To better define, in women with headache, the relationship of depression and somatic symptoms to headache, characterized by diagnoses, frequency, and disability...
Practical use of topiramate for migraine preventionJan Lewis Brandes
Nashville Neuroscience Group and Department of Neurology, Vanderbilt University Medical School, TN 37203, USA
Headache 45:S66-73. 2005..The practical issues discussed in this article will enable clinicians to maximize the effectiveness while minimizing the side effects associated with this preventive agent...
The migraine cycle: patient burden of migraine during and between migraine attacksJan Lewis Brandes
Nashville Neuroscience Group, Nashville, TN, USA
Headache 48:430-41. 2008..Nevertheless, patients with frequent and recurring migraines, who suffer a reduced QoL, continue to be underrecognized and undertreated. This segment of the migraine population could benefit from preventive therapy...
Global trends in migraine care: results from the MAZE surveyJan Lewis Brandes
Vanderbilt University School of Medicine, Nashville, Tennessee, USA
CNS Drugs 16:13-8. 2002..Physicians particularly need to reach patients who do not realise they have migraine and those who have lapsed from care...
Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tabletsFred D Sheftell
New England Center for Headache, Stamford, Connecticut 06902 1227, USA
Clin Ther 27:407-17. 2005..A fast-disintegrating/rapid-release formulation of sumatriptan has been developed to enhance tablet disintegration and drug dispersion and potentially improve absorption...
